AEVEX Tests IPO Demand for Defense Autonomy

LOS ANGELES, April 14, 2026 - AEVEX is not the sleepy government-services name its revenue line might suggest. The Solana Beach defense-technology contractor is trying to sell public investors on one of the cleanest IPO themes in the market: autonomous systems, loitering munitions and ISR capacity at a time when drone procurement has moved from niche budget item to strategic priority.

The terms give the deal real weight. AEVEX is offering 16 million Class A shares at $18 to $21, a $288 million to $336 million raise before expenses, with an NYSE application under the symbol AVEX. At the midpoint, the company would raise $312 million. At the top of the range, Reuters calculated the targeted valuation at about $2.35 billion.

The bank group also looks built for a full institutional test. Goldman Sachs, BofA Securities and Jefferies are joint lead bookrunning managers, followed by J.P. Morgan, RBC Capital Markets and Baird as bookrunning managers, William Blair, Raymond James and Needham as bookrunners, and Academy Securities, Capital One Securities and PNC Capital Markets as co-managers.

AEVEX's pitch is scale plus battlefield relevance. The company says it has delivered more than 6,200 autonomous systems and has more than 3,900 more committed through the end of 2026. Its Phoenix Ghost and EUCOM AOR Deep Strike programs alone represent more than 9,300 systems delivered and committed through 2026 and more than $1.2 billion of total contract value. Funded backlog rose 181% in 2025, from $179.2 million to $503.1 million, while the identified opportunity pipeline nearly doubled to $8.1 billion.

That is the bull case. The check on it is that the IPO is not coming off a clean margin story.

Revenue rose 10.4% last year to $432.9 million from $392.2 million, but gross profit fell to $94.3 million from $110.3 million. Gross margin compressed to 21.8% from 28.1%, with product margin hit by higher costs and startup costs tied to the EUCOM AOR Deep Strike program. Net income swung to a $16.8 million loss from $78.6 million of profit, and adjusted EBITDA fell to $37.6 million from $77.0 million.

That makes the use of proceeds important. AEVEX says proceeds will flow through its Up-C structure to Holdings LLC, which plans to repay outstanding borrowings under its existing credit agreement. The company also expects to put new credit facilities in place after the IPO, including an expected $100 million term loan, a $75 million delayed-draw term loan facility and a $200 million revolver, though those facilities are not committed.

Control will remain concentrated. Madison Dearborn Partners' funds are expected to hold roughly 79.1% of the combined voting power immediately after the offering, assuming the base deal size, leaving AEVEX as a controlled company under NYSE standards. Public buyers are therefore underwriting the growth of the platform, not a shift in control.

The deal deserves attention because it is an unusually direct test of public-market appetite for defense autonomy. There is no disclosed cornerstone investor or concurrent private placement giving the book an obvious anchor. Instead, AEVEX is coming with a large backlog number, a defense-heavy customer story, sponsor control, a debt-repayment use of proceeds and a margin reset that investors will have to decide is temporary program friction or a more durable cost problem.

If the IPO clears inside the range, AVEX would give the calendar a rare pure-play read on drone demand rather than another broad aerospace supplier. If it struggles, the message will be just as useful: even in a market that likes defense exposure, growth tied to urgent procurement still has to carry public-company margins.